State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.

By R. Müller, S. Gohla, C. Keck. European journal of pharmaceutics and biopharmaceutics, 2011

652 citations recorded by the source corpus.

Subfields: Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/2e003e8cc526ee85bd0df5ab463b2ccf24e7f982

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pharmaceutical Science

1. Christopher J. H. Porter
2. W. Charman
3. Natalie L. Trevaskis
4. S. Charman
5. H. Williams
6. R. Shanker
7. Colin W. Pouton
8. D. McClements

Citations in the corpus

• Strategies to Address Low Drug Solubility in Discovery and Development (2013, background): “SLN formulations also provide opportunities for targeted therapies; however, these lie beyond the scope of this review [see Muller et al. (2011b) and Joshi and Müller (2009) for details].”